Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_2265Herpes simplex virusEquine Herpesvirus type-1DNAHerpesviridaeNoneYesNoNoNAHuman glioma cell lineSNB19NANAMTS assay10 MOI60% cell survival after 48 hoursNoNoNA No responseNANANANA22205738
OV_2266Herpes simplex virusEquine Herpesvirus type-1DNAHerpesviridaeNoneYesNoNoNAHuman glioma cell lineLN-18NANAMTS assay10 MOI30% cell survival after 48 hoursNoNoNA No responseNANANANA22205738
OV_2267Herpes simplex virusEquine Herpesvirus type-1DNAHerpesviridaeNoneYesNoNoNAHuman glioma cell lineA-172NANAMTS assay10 MOI30% cell survival after 48 hoursNoNoNA No responseNANANANA22205738
OV_3138Herpes simplex virusHSV-HSV-GRDNAHerpesviridaeDeletion of gamma 34.5 gene and insertion of GR and mcherryYesNoNoNational cell bak of IranMurine breast cancer cell line4T1NANAPhotomicrography and flow cytometry1 MOI27.9% cancer cell killingNoNoNA No responseNANANANA30936930
OV_3139Herpes simplex virusHSV-HSV-GRDNAHerpesviridaeDeletion of gamma 34.5 gene and insertion of GR and mcherryYesNoNoNational cell bak of IranMurine breast cancer cell lineTC-1NANAPhotomicrography and flow cytometry1 MOI21.2% cancer cell killingNoNoNA No responseNANANANA30936930
OV_3140Herpes simplex virusHSV-HSV-GRDNAHerpesviridaeDeletion of gamma 34.5 gene and insertion of GR and mcherryYesNoNoNational cell bak of IranMurine breast cancer cell lineCT-26NANAPhotomicrography and flow cytometry1 MOI21.3% cancer cell killingNoNoNA No responseNANANANA30936930
OV_3141Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay5 MOI50% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3142Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay10 MOI25% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3143Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay20 MOI18% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3144Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay5 MOI50% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3145Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay10 MOI30% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3146Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay20 MOI25% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3147Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay10 MOI90% cell viability after day 1NoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3148Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay10 MOI60% cell viability after day 2NoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3149Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay10 MOI40% cell viability after day 3NoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3150Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay10 MOI10% cell viability after day 4NoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3151Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay10 MOI90% cell viability after day 1NoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3152Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay10 MOI80% cell viability after day 2NoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3153Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay10 MOI70% cell viability after day 3NoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3154Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay10 MOI40% cell viability after day 4NoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3155Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW620NANANANANAMouse model xenograft for SW620 (1.0E+6)5.0E+8 pfuNA Reduction in tumor volume below 200mm as compared to control 2500mm after 24 daysIntratumoralCaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3156Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneYesNoNoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174TNANANANANAMouse model xenograft for LS174T (1.0E+6)5.0E+8 pfuNA Reduction in tumor volume below 500mm as compared to control 3000mm after 24 daysIntratumoralCaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3157Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneNoVirus in combination with rapamycin (5nM)NoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay5 MOI60% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3158Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneNoVirus in combination with rapamycin (10nM)NoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay10 MOI50% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3159Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneNoVirus in combination with rapamycin (20nM)NoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineSW6202000 cells per wellNACCK-8 assay20 MOI40% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3160Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneNoVirus in combination with rapamycin (5nM)NoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay5 MOI70% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3161Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneNoVirus in combination with rapamycin (10nM)NoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay10 MOI50% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3162Herpes simplex virusSPDD-UGDNAAdenoviridaeVirus expressing SNORD44 gene and GAS5 geneNoVirus in combination with rapamycin (20nM)NoCell bank of type culture collection of chinese academy of scienceHuman colon carcinoma cell lineLS174T2000 cells per wellNACCK-8 assay20 MOI40% cell viabilityNoNoNA No responseNACaspase dependent Induction of apoptosis as measured by TUNEL assay in both tumor model and cell lineNANA28530127
OV_3177Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman edwig sarcoma cell lineRD-ES90% confluenceNACrystal violet staining and absorbance at 595 nm0.0001 MOI60% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3178Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman edwig sarcoma cell lineRD-ES90% confluenceNACrystal violet staining and absorbance at 595 nm0.001 MOI50% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3179Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman edwig sarcoma cell lineRD-ES90% confluenceNACrystal violet staining and absorbance at 595 nm0.01 MOI30% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3180Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman edwig sarcoma cell lineRD-ES90% confluenceNACrystal violet staining and absorbance at 595 nm0.1 MOI30% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3181Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman edwig sarcoma cell lineRD-ES90% confluenceNACrystal violet staining and absorbance at 595 nm1 MOI30% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3182Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman edwig sarcoma cell lineRD-ES90% confluenceNACrystal violet staining and absorbance at 595 nm10 MOI30% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3207Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman bone osteosarcoma cell line143-B90% confluenceNACrystal violet staining and absorbance at 595 nm0.0001 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3208Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman bone osteosarcoma cell line143-B90% confluenceNACrystal violet staining and absorbance at 595 nm0.001 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3209Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman bone osteosarcoma cell line143-B90% confluenceNACrystal violet staining and absorbance at 595 nm0.01 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3210Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman bone osteosarcoma cell line143-B90% confluenceNACrystal violet staining and absorbance at 595 nm0.1 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3211Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman bone osteosarcoma cell line143-B90% confluenceNACrystal violet staining and absorbance at 595 nm1 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3212Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman bone osteosarcoma cell line143-B90% confluenceNACrystal violet staining and absorbance at 595 nm10 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3237Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman canine osteosarcomaD1790% confluenceNACrystal violet staining and absorbance at 595 nm0.0001 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3238Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman canine osteosarcomaD1790% confluenceNACrystal violet staining and absorbance at 595 nm0.001 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3239Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman canine osteosarcomaD1790% confluenceNACrystal violet staining and absorbance at 595 nm0.01 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3240Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman canine osteosarcomaD1790% confluenceNACrystal violet staining and absorbance at 595 nm0.1 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3241Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman canine osteosarcomaD1790% confluenceNACrystal violet staining and absorbance at 595 nm1 MOI90% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3242Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman canine osteosarcomaD1790% confluenceNACrystal violet staining and absorbance at 595 nm10 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3267Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman synovial sarcoma cell lineSW98290% confluenceNACrystal violet staining and absorbance at 595 nm0.0001 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3268Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman synovial sarcoma cell lineSW98290% confluenceNACrystal violet staining and absorbance at 595 nm0.001 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3269Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman synovial sarcoma cell lineSW98290% confluenceNACrystal violet staining and absorbance at 595 nm0.01 MOI80% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3270Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman synovial sarcoma cell lineSW98290% confluenceNACrystal violet staining and absorbance at 595 nm0.1 MOI75% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3271Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman synovial sarcoma cell lineSW98290% confluenceNACrystal violet staining and absorbance at 595 nm1 MOI75% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_3272Herpes simplex viruswild typeDNAHerpesviridaeNoneYesNoNoATCCHuman synovial sarcoma cell lineSW98290% confluenceNACrystal violet staining and absorbance at 595 nm10 MOI75% cell survival after 48 hoursNoNoNA No responseNANAGenration of memory immune response by incresing production of cytokinesNA28568891
OV_4077Herpes simplex virusG207DNAHerpesviridaeDeletion mutant for gamma 34.5 gene and and lacZ insertion into Ul39 gene encodes for ICP6 geneYesNoNoDuke university medical centreNANANANANANANANude mice xenograft for medulloblastoma cell line D425 (2.5E+5)1.0E+7 pfuNA Increase the survival time of mice from 15 days to 25 daysIntratumoralNAIncreased expression of CD133 and CD15NA26188016
OV_4078Herpes simplex virusG207DNAHerpesviridaeDeletion mutant for gamma 34.5 gene and and lacZ insertion into Ul39 gene encodes for ICP6 geneYesNoNoDuke university medical centreNANANANANANANANude mice xenograft for medulloblastoma cell line D341 (5.0E+5)1.0E+7 pfuNA Increase the survival time of mice from 32 days to above 60 daysIntratumoralNAIncreased expression of CD133 and CD15NA26188016
OV_4079Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for gamma 34.5 geneYesNoVirus expressing murine IL-12 geneDuke university medical centreNANANANANANANANude mice xenograft for medulloblastoma cell line D425 (2.5E+5)1.0E+7 pfuNA Increase the survival time of mice from 20 days to above 90 daysIntratumoralNAIncreased expression of CD133 and CD15NA26188016
OV_4080Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for gamma 34.5 geneYesNoVirus expressing murine IL-12 geneDuke university medical centreNANANANANANANANude mice xenograft for medulloblastoma cell line D341 (5.0E+5)1.0E+7 pfuNA Increase the survival time of mice from 30 days to above 60 daysIntratumoralNAIncreased expression of CD133 and CD15NA26188016
OV_4442Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN34000 to 5000 cells per wellNAMTS assay0.03 MOI78% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4443Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN34000 to 5000 cells per wellNAMTS assay0.1 MOI18% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4444Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN34000 to 5000 cells per wellNAMTS assay0.3 MOI1% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4445Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN34000 to 5000 cells per wellNAMTS assay1 MOI100% cell killing after 96 hoursNoNoNA No responseNANANANA26951380
OV_4446Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN74000 to 5000 cells per wellNAMTS assay0.001 MOI68% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4447Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN74000 to 5000 cells per wellNAMTS assay0.003 MOI40% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4448Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN74000 to 5000 cells per wellNAMTS assay0.01 MOI22% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4449Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN74000 to 5000 cells per wellNAMTS assay0.03 MOI18% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4450Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN74000 to 5000 cells per wellNAMTS assay0.1 MOI16% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4451Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN74000 to 5000 cells per wellNAMTS assay0.3 MOI16% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4452Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN74000 to 5000 cells per wellNAMTS assay1 MOI16% cell survival after 96 hoursNoNoNA No responseNANANANA26951380
OV_4453Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4654000 to 5000 cells per wellNAMTS assay0.04 MOI45% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4454Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4754000 to 5000 cells per wellNAMTS assay0.04 MOI45% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4455Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN2984000 to 5000 cells per wellNAMTS assay0.04 MOI70% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4456Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN14000 to 5000 cells per wellNAMTS assay0.04 MOI30% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4457Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4654000 to 5000 cells per wellNAMTS assay0.11 MOI30% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4458Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4754000 to 5000 cells per wellNAMTS assay0.11 MOI35% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4459Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN2984000 to 5000 cells per wellNAMTS assay0.11 MOI55% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4460Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN14000 to 5000 cells per wellNAMTS assay0.11 MOI20% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4461Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4654000 to 5000 cells per wellNAMTS assay0.33 MOI20% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4462Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4754000 to 5000 cells per wellNAMTS assay0.33 MOI20% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4463Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN2984000 to 5000 cells per wellNAMTS assay0.33 MOI50% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4464Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN14000 to 5000 cells per wellNAMTS assay0.33 MOI10% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4465Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4654000 to 5000 cells per wellNAMTS assay1 MOI15% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4466Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4754000 to 5000 cells per wellNAMTS assay1 MOI15% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4467Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN2984000 to 5000 cells per wellNAMTS assay1 MOI30% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4468Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN14000 to 5000 cells per wellNAMTS assay1 MOI5% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4469Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4654000 to 5000 cells per wellNAMTS assay3 MOI10% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4470Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN4754000 to 5000 cells per wellNAMTS assay3 MOI12% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4471Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN2984000 to 5000 cells per wellNAMTS assay3 MOI25% cell viablity after 96 hoursNoNoNA No responseNANANANA26951380
OV_4472Herpes simplex virusG47-delta-mCherryDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoHuman patientmalignant leningiomaMN14000 to 5000 cells per wellNAMTS assay3 MOI100% cell killing after 96 hoursNoNoNA No responseNANANANA26951380
OV_4473Herpes simplex virusG47-deltaDNAHerpesviridaeDeletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6YesNoNoNANANANANANANANASCID mice orthotopic xenograft for MN3 cell (75000 cells)2.0E+6 pfu on day 14 and 25 post tumor cell implantationNA Survival time increased from control 80 days to 160 days in virus trated groupIntratumoralNANANA26951380
OV_4483Herpes simplex virusRH2DNAHerpesviridaeMutant for Gamma 34.5 gene and gB geneYesNoNoNAMurine squamous cell carcinomaSCCVIINANAMTT assay10 MOI70% cell survival after 12 hoursNoNoNA No responseNAVirus induced apoptosisIncreased extracellular ATP and HMGB1, indicating immunogenic cell deathNA26987291
OV_4484Herpes simplex virusRH2DNAHerpesviridaeMutant for Gamma 34.5 gene and gB geneYesNoNoNAMurine squamous cell carcinomaSCCVIINANAMTT assay10 MOI60% cell survival after 12 hoursNoNoNA No responseNAVirus induced apoptosisIncreased extracellular ATP and HMGB1, indicating immunogenic cell deathNA26987291
OV_4485Herpes simplex virusRH2DNAHerpesviridaeMutant for Gamma 34.5 gene and gB geneYesNoNoNAMurine squamous cell carcinomaSCCVIINANAMTT assay10 MOI50% cell survival after 12 hoursNoNoNA No responseNAVirus induced apoptosisIncreased extracellular ATP and HMGB1, indicating immunogenic cell deathNA26987291
OV_4486Herpes simplex virusRH2DNAHerpesviridaeMutant for Gamma 34.5 gene and gB geneYesNoNoNAMurine squamous cell carcinomaSCCVIINANAMTT assay100 MOI50% cell survival after 12 hoursNoNoNA No responseNAVirus induced apoptosisIncreased extracellular ATP and HMGB1, indicating immunogenic cell deathNA26987291
OV_4487Herpes simplex virusRH2DNAHerpesviridaeMutant for Gamma 34.5 gene and gB geneYesNoNoNAMurine squamous cell carcinomaSCCVIINANAMTT assay100 MOI40% cell survival after 12 hoursNoNoNA No responseNAVirus induced apoptosisIncreased extracellular ATP and HMGB1, indicating immunogenic cell deathNA26987291
OV_4488Herpes simplex virusRH2DNAHerpesviridaeMutant for Gamma 34.5 gene and gB geneYesNoNoNAMurine squamous cell carcinomaSCCVIINANAMTT assay100 MOI30% cell survival after 12 hoursNoNoNA No responseNAVirus induced apoptosisIncreased extracellular ATP and HMGB1, indicating immunogenic cell deathNA26987291
OV_4489Herpes simplex virusRH2DNAHerpesviridaeMutant for Gamma 34.5 gene and gB geneYesNoNoNANANANANANANANAC3H mice subcutaneous implanted for SCCVII (1.0E+6)50 microliter of RH2 virus, 3 times at interval of 2 daysNA Tumor volume was less than 1587 cubic mm in treated mice compared to control 2996 cubic mm after 25 daysIntratumoralVirus induced apoptosisIncreased extracellular ATP and HMGB1, indicating immunogenic cell deathNA26987291
OV_4656Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineCAL27NANAStatistical analysis0.001 MOI82% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4657Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineCAL27NANAStatistical analysis0.005 MOI42% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4658Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineCAL27NANAStatistical analysis0.01 MOI38% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4659Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineCAL27NANAStatistical analysis0.05 MOI30% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4660Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineCAL27NANAStatistical analysis0.1 MOI30% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105